← Leaderboards
Maureen A McCall
University Of Louisville
$9,064,261
Attributed
$16,171,662
Total exposure
11
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,171,662 · 11
By mechanism
R01$15,261,395 · 7
R21$436,237 · 1
R13$300,602 · 2
T35$173,428 · 1
Top collaborators
- Ronald G Gregg13 shared
- Douglas Chase Dean5 shared
- Astra Dinculescu5 shared
- Nazarul Hasan5 shared
- Brian P. Ceresa4 shared
- Brian A Link3 shared
- Henry Jerrold Kaplan2 shared
- Aaron W Mcgee2 shared
Most similar at University Of Louisville
Same institution · by research overlap
- Ronald G Gregg$9,907,325
- Douglas Chase Dean$9,729,332
- Nazarul Hasan$738,474
Others in their field
Top investigators on “Retina”
- Keri Hammel · The Emmes Company, Llc$53,700,408
- Krzysztof Palczewski · University Of California-Irvine$48,214,939
- Adam R Glassman · Jaeb Center For Health Research, Inc.$47,242,041
- Cecilia Sungmin Lee · University Of Washington$32,086,169
- Adam Glassman · Jaeb Center For Health Research, Inc.$31,583,813
- Karen J Cruickshanks · University Of Wisconsin Madison$28,499,261
Research focus
RetinaVisionVisualCellsLightStructureGenesMutantResponseMorphologyRetinal DiseasesSignal TransductionMutationNight BlindnessPhotoreceptorsSynapsesMediatingElectroretinographyReceptorRestBlindnessAffectSeriesRetinal
Grant awards (48)
CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3$671,103
R01 · FY2025 · EY
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.$574,292
R01 · FY2025 · EY · contact PI
The role of plasticity in loss of vision caused by retinitis pigmentosa$304,804
R01 · FY2025 · EY
Summer Vision Sciences Training Program$54,554
T35 · FY2025 · EY
CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3$706,003
R01 · FY2024 · EY
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.$568,819
R01 · FY2024 · EY · contact PI
The role of plasticity in loss of vision caused by retinitis pigmentosa$463,927
R01 · FY2024 · EY
Summer Vision Sciences Training Program$50,012
T35 · FY2024 · EY
CLARIN 1 RETINAL FUNCTION AND THERAPEUTIC IMPLICATIONS FOR USH3$710,591
R01 · FY2023 · EY
Preclinical evaluation of a homing endonuclease gene therapy for adRP in models of P23H retinopathy.$523,726
R01 · FY2023 · EY · contact PI
Glycine subunit specific inhibition and ganglion cell visual responses$465,562
R01 · FY2023 · EY · contact PI
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3$192,577
R21 · FY2023 · EY
Summer Vision Sciences Training Program$33,085
T35 · FY2023 · EY
Glycine subunit specific inhibition and ganglion cell visual responses$466,146
R01 · FY2022 · EY · contact PI
Generation and Characterization of Novel Large Animal Models of Usher Syndrome Type 3$243,660
R21 · FY2022 · EY
Summer Vision Sciences Training Program$35,777
T35 · FY2022 · EY
Glycine subunit specific inhibition and ganglion cell visual responses$611,643
R01 · FY2021 · EY · contact PI
Isolation of Congenital Stationary Night Blindness Genes$527,373
R01 · FY2021 · EY
Glycine subunit specific inhibition and ganglion cell visual responses$563,572
R01 · FY2020 · EY · contact PI
Isolation of Congenital Stationary Night Blindness Genes$543,685
R01 · FY2020 · EY
Cone Rescue in Retinitis Pigmentosa$607,017
R01 · FY2019 · EY
Isolation of Congenital Stationary Night Blindness Genes$543,685
R01 · FY2019 · EY
Glycine subunit specific inhibition and ganglion cell visual responses$539,481
R01 · FY2019 · EY · contact PI
Cone Rescue in Retinitis Pigmentosa$610,659
R01 · FY2018 · EY
Isolation of Congenital Stationary Night Blindness Genes$543,685
R01 · FY2018 · EY
Cone Rescue in Retinitis Pigmentosa$73,249
R01 · FY2018 · EY
Isolation of Congenital Stationary Night Blindness Genes$56,995
R01 · FY2018 · EY
Cone Rescue in Retinitis Pigmentosa$588,677
R01 · FY2017 · EY
Cone Rescue in Retinitis Pigmentosa$532,383
R01 · FY2016 · EY
FASEB SRC Retinal Neurobiology & Visual Processing$69,800
R13 · FY2016 · EY · contact PI
FASEB SRC Retinal Neurobiology & Visual Processing$31,401
R13 · FY2015 · EY · contact PI
Ganglion Cell Function in Retinal Disease$367,991
R01 · FY2014 · EY · contact PI
FASEB SRC Retinal Neurobiology & Visual Processing$69,800
R13 · FY2014 · EY · contact PI
Ganglion Cell Function in Retinal Disease$356,726
R01 · FY2013 · EY · contact PI
FASEB SRC Retinal Neurobiology & Visual Processing$1
R13 · FY2013 · EY · contact PI
Ganglion Cell Function in Retinal Disease$375,501
R01 · FY2012 · EY · contact PI
FASEB SRC Retinal Neurobiology & Visual Processing$73,800
R13 · FY2012 · EY · contact PI
Ganglion Cell Function in Retinal Disease$380,278
R01 · FY2011 · EY · contact PI
Ganglion Cell Function in Retinal Disease$75,000
R01 · FY2011 · EY · contact PI
Ganglion Cell Function in Retinal Disease$18,585
R01 · FY2011 · EY · contact PI
Ganglion Cell Function in Retinal Disease$532,998
R01 · FY2010 · EY · contact PI
FASEB Summer Research Conference on Retinal Neurobiology and Visual Processing$55,800
R13 · FY2010 · EY · contact PI
GABAc Receptors & Mouse Retinal Ganglion Cell Responses$34,218
R01 · FY2009 · EY · contact PI
GABAc Receptors & Mouse Retinal Ganglion Cell Responses$307,429
R01 · FY2007 · EY · contact PI
GABAc Receptors & Mouse Retinal Ganglion Cell Responses$83,913
R01 · FY2007 · EY · contact PI
GABAc Receptors & Mouse Retinal Ganglion Cell Responses$309,123
R01 · FY2006 · EY · contact PI
GABAc Receptors &Mouse Retinal Ganglion Cell Responses$322,722
R01 · FY2005 · EY
GABAc Receptors &Mouse Retinal Ganglion Cell Responses$299,834
R01 · FY2004 · EY